Role of α7- and α4β2-nAChRs in the neuroprotective effect of nicotine in stress-induced impairment of hippocampus-dependent memory

International Journal of Neuropsychopharmacology

Volumn 16, Issue 5, 2013, Pages 1105-1113

  Alzoubi, Karem H ^a   Srivareerat, Marisa ^b   Tran, Trinh T ^b   Alkadhi, Karim A ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

DH E; Long term memory; MLA; RAWM; short term memory

Indexed keywords

ALPHA4BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR; BUNGAROTOXIN RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; LONG TERM MEMORY; MALE; MEMORY DISORDER; MENTAL STRESS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SPATIAL MEMORY;

ACONITINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANALYSIS OF VARIANCE; ANIMALS; DIHYDRO-BETA-ERYTHROIDINE; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84878003438     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001046     Document Type: Article

References (91)

1. Akaike A, Takada-Takatori Y, Kume T, Izumi Y (2010). Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. Journal of Molecular Neuroscience 40, 211-216.
2. Aleisa AM, Alzoubi KH, Alkadhi KA (2006a). Chronic but not acute nicotine treatment reverses stress-induced impairment of LTP in anesthetized rats. Brain Research 1097, 78-84.
3. Aleisa AM, Alzoubi KH, Alkadhi KA (2006b). Nicotine prevents stress-induced enhancement of long-term depression in hippocampal area CA1: electrophysiological and molecular studies. Journal of Neuroscience Research 83, 309-317.
4. Aleisa AM, Alzoubi KH, Alkadhi KA (2011a). Post-learning REM sleep deprivation impairs long-term memory: reversal by acute nicotine treatment. Neuroscience Letters 499, 28-31.
5. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA (2006c). Chronic psychosocial stress-induced impairment of hippocampal LTP: possible role of BDNF. Neurobiology of Disease 22, 453-462.
6. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA (2006d). Nicotine blocks stress-induced impairment of spatial memory and long-term potentiation of the hippocampal CA1 region. International Journal of Neuropsychopharmacology 9, 417-426.
7. Aleisa AM, Helal G, Alhaider IA, Alzoubi KH, et al. (2011b). Acute nicotine treatment prevents REM sleep deprivation-induced learning and memory impairment in rat. Hippocampus 21, 899-909.
8. Alkadhi KA, Alzoubi KH, Aleisa AM, Nimer AS (2005). Psychosocial stress-induced hypertension results from in vivo expression of long-term potentiation in sympathetic ganglia. Neurobiology of Disease 20, 849-857.
9. Alkadhi KA, Alzoubi KH, Srivareerat M, Tran TT (2011). Chronic psychosocial stress exacerbates impairment of synaptic plasticity in beta-amyloid rat model of Alzheimer's disease: prevention by nicotine. Current Alzheimer Research 8, 718-731.
10. Alkadhi KA, Alzoubi KH, Srivareerat M, Tran TT (2012). Elevation of BACE in an Abeta rat model of Alzheimer's disease: exacerbation by chronic stress and prevention by nicotine. International Journal of Neuropsychopharmacology 15, 223-233.
11. Alkadhi KA, Srivareerat M, Tran TT (2010). Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease. Molecular and Cellular Neuroscience 45, 289-296.
12. Alkondon M, Braga MF, Pereira EF, Maelicke A, et al. (2000). Alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. European Journal of Pharmacology 393, 59-67.
13. Alzoubi KH, Abdul-Razzak KK, Khabour OF, Al-Tuweiq GM, et al. (2009). Adverse effect of combination of chronic psychosocial stress and high fat diet on hippocampus-dependent memory in rats. Behavioural Brain Research 204, 117-123.
14. Alzoubi KH, Aleisa AM, Gerges NZ, Alkadhi KA (2006). Nicotine reverses adult-onset hypothyroidism-induced impairment of learning and memory: behavioral and electrophysiological studies. Journal of Neuroscience Research 84, 944-953.
15. Alzoubi KH, Gerges NZ, Alkadhi KA (2005). Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: electrophysiological and molecular studies. Experimental Neurology 195, 330-341.
16. Alzoubi KH, Khabour OF, Rashid BA, Damaj IM, et al. (2012). The neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress. Behavioural Brain Research 226, 205-210.
17. Bancroft A, Levin ED (2000). Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 39, 2770-2778.
18. Bencan Z, Levin ED (2008). The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. Physiology and Behavior 95, 408-412.
19. Benowitz NL (1986). Clinical pharmacology of nicotine. Annual Review of Medicine 37, 21-32.
20. Benowitz NL, Jacob 3rd P, Denaro C, Jenkins R (1991). Stable isotope studies of nicotine kinetics and bioavailability. Clinical Pharmacology and Therapeutics 49, 270-277.
21. Bertrand D, Galzi JL, Devillers-Thiery A, Bertrand S, et al. (1993). Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proceedings of the National Academy of Sciences USA 90, 6971-6975.
22. Bettany JH, Levin ED (2001). Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze. Pharmacology Biochemistry and Behavior 70, 467-474.
23. Brandt SK, Weatherly ME, Ware L, Linn DM, et al. (2011). Calcium preconditioning triggers neuroprotection in retinal ganglion cells. Neuroscience 172, 387-397.
24. Buckingham SD, Jones AK, Brown LA, Sattelle DB (2009). Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacological Reviews 61, 39-61.
25. Cannady R, Weir R, Wee B, Gotschlich E, et al. (2009). Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function. Biochemical Pharmacology 78, 788-794.
26. Carrasco C, Vicens P, Redolat R (2006). Neuroprotective effects of behavioural training and nicotine on age-related deficits in spatial learning. Behavioural Pharmacology 17, 441-452.
27. Dajas-Bailador FA, Lima PA, Wonnacott S (2000). The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism. Neuropharmacology 39, 2799-2807.
28. Diamond DM, Park CR, Heman KL, Rose GM (1999). Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus 9, 542-552.
29. Dunne MP, Macdonald D, Hartley LR (1986). The effects of nicotine upon memory and problem solving performance. Physiology and Behavior 37, 849-854.
30. Egea J, Rosa AO, Sobrado M, Gandia L, et al. (2007). Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice. Neuroscience 145, 866-872.
31. Escubedo E, Camarasa J, Chipana C, Garcia-Rates S, et al. (2009). Involvement of nicotinic receptors in methamphetamine-and MDMA-induced neurotoxicity: pharmacological implications. International Review of Neurobiology 88, 121-166.
32. File SE, Fluck E, Leahy A (2001). Nicotine has calming effects on stress-induced mood changes in females, but enhances aggressive mood in males. International Journal of Neuropsychopharmacology 4, 371-376.
33. Fujii S, Ji Z, Morita N, Sumikawa K (1999). Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Research 846, 137-143.
34. Gerges NZ, Alzoubi KH, Park CR, Diamond DM, et al. (2004). Adverse effect of the combination of hypothyroidism and chronic psychosocial stress on hippocampus-dependent memory in rats. Behavioural Brain Research 155, 77-84.
35. Gerges NZ, Stringer JL, Alkadhi KA (2001). Combination of hypothyroidism and stress abolishes early LTP in the CA1 but not dentate gyrus of hippocampus of adult rats. Brain Research 922, 250-260.
36. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, et al. (1996). Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716.
37. Harris JG, Kongs S, Allensworth D, Martin L, et al. (2004). Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29, 1378-1385.
38. Jacob 3rd P, Benowitz NL, Shulgin AT (1988). Recent studies of nicotine metabolism in humans. Pharmacology Biochemistry and Behavior 30, 249-253.
39. Ji D, Lape R, Dani JA (2001). Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31, 131-141.
40. Jones GM, Sahakian BJ, Levy R, Warburton DM, et al. (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berlin) 108, 485-494.
41. Jubelt LE, Barr RS, Goff DC, Logvinenko T, et al. (2008). Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology (Berlin) 199, 89-98.
42. Kandel ER (2001). The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038.
43. Kawamata J, Shimohama S (2011). Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. Journal of Alzheimer's Disease 24 (Suppl. 2), 95-109.
44. Kawamata J, Suzuki S, Shimohama S (2012). Proportional, variant7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease. Current Drug Targets 13, 623-630.
45. Kelton MC, Kahn HJ, Conrath CL, Newhouse PA (2000). The effects of nicotine on Parkinson's disease. Brain and Cognition 43, 274-282.
46. Khabour OF, Alzoubi KH, Alomari MA, Alzubi MA (2010). Changes in spatial memory and BDNF expression to concurrent dietary restriction and voluntary exercise. Hippocampus 20, 637-645.
47. Khantzian EJ (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 4, 231-244.
48. Le Houezec J, Jacob 3rd P, Benowitz NL (1993). A clinical pharmacological study of subcutaneous nicotine. European Journal of Clinical Pharmacology 44, 225-230.
49. Levin ED (2002). Nicotinic receptor subtypes and cognitive function. Journal of Neurobiology 53, 633-640.
50. Levin ED (2012). Proportional, variant7 nicotinic receptors and cognition. Current Drug Targets 13, 602-606.
51. Levin ED, Bradley A, Addy N, Sigurani N (2002). Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 109, 757-765.
52. Levin ED, Briggs SJ, Christopher NC, Rose JE (1993). Chronic nicotinic stimulation and blockade effects on working memory. Behavioural Pharmacology 4, 179-182.
53. Levin ED, Castonguay M, Ellison GD (1987). Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behavioral and Neural Biology 48, 206-212.
54. Levin ED, Christopher NC, Briggs SJ (1997). Chronic nicotinic agonist and antagonist effects on T-maze alternation. Physiology and Behavior 61, 863-866.
55. Levin ED, Conners CK, Silva D, Canu W, et al. (2001). Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Experimental and Clinical Psychopharmacology 9, 83-90.
56. Levin ED, McClernon FJ, Rezvani AH (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berlin) 184, 523-539.
57. Levin ED, Perkins A, Brotherton T, Qazi M, et al. (2009). Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33, 296-302.
58. Mansvelder HD, McGehee DS (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27, 349-357.
59. Mugnaini M, Tessari M, Tarter G, Merlo Pich E, et al. (2002). Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. European Journal of Neuroscience 16, 1633-1646.
60. Nott A, Levin ED (2006). Dorsal hippocampal alpha7 and alpha4beta2 nicotinic receptors and memory. Brain Research 1081, 72-78.
61. Pacini A, Di Cesare Mannelli L, Bonaccini L, Ronzoni S, et al. (2010). Protective effect of alpha7 nAChR: behavioural and morphological features on neuropathy. Pain 150, 542-549.
62. Park CR, Campbell AM, Diamond DM (2001). Chronic psychosocial stress impairs learning and memory and increases sensitivity to yohimbine in adult rats. Biological Psychiatry 50, 994-1004.
63. Park S, Knopick C, McGurk S, Meltzer HY (2000). Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology 22, 200-209.
64. Parker SL, Fu Y, McAllen K, Luo J, et al. (2004). Up-regulation of brain nicotinic acetylcholine receptors in the rat during long-term self-administration of nicotine: disproportionate increase of the alpha6 subunit. Molecular Pharmacology 65, 611-622.
65. Parrott AC, Winder G (1989). Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate. Psychopharmacology (Berlin) 97, 257-261.
66. Pauly JR, Collins AC (1993). An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation. Neuroendocrinology 57, 262-271.
67. Pocivavsek A, Icenogle L, Levin ED (2006). Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. Psychopharmacology (Berlin) 188, 597-604.
68. Poltavski DV, Petros T (2006). Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiology and Behavior 87, 614-624.
69. Potter AS, Newhouse PA (2008). Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacology Biochemistry and Behavior 88, 407-417.
70. Ridley DL, Rogers A, Wonnacott S (2001). Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. British Journal of Pharmacology 133, 1286-1295.
71. Roncarati R, Scali C, Comery TA, Grauer SM, et al. (2009). Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders. Journal of Pharmacology and Experimental Therapeutics 329, 459-468.
72. Rosa AO, Egea J, Gandia L, Lopez MG, et al. (2006). Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype. Journal of Molecular Neuroscience 30, 61-62.
73. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, et al. (1993). Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. Journal of Neuroscience 13, 596-604.
74. Shen H, Kihara T, Hongo H, Wu X, et al. (2010). Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. British Journal of Pharmacology 161, 127-139.
75. Shen JX, Yakel JL (2009). Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacologica Sinica 30, 673-680.
76. Smith RC, Singh A, Infante M, Khandat A, et al. (2002). Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27, 479-497.
77. Sorenson CA, Raskin LA, Suh Y (1991). The effects of prenatal nicotine on radial-arm maze performance in rats. Pharmacology Biochemistry and Behavior 40, 991-993.
78. Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA (2009). Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease. Biological Psychiatry 65, 918-926.
79. Srivareerat M, Tran TT, Salim S, Aleisa AM, et al. (2011). Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiology of Aging 32, 834-844.
80. Swan GE, Lessov-Schlaggar CN (2007). The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychology Review 17, 259-273.
81. Takeuchi H, Yanagida T, Inden M, Takata K, et al. (2009). Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models. Journal of Neuroscience Research 87, 576-585.
82. Takita M, Muramatsu I (1995). Alteration of brain nicotinic receptors induced by immobilization stress and nicotine in rats. Brain Research 681, 190-192.
83. Takita M, Taniguchi T, Zhu J, Piao HL, et al. (1999). Effects of chronic treatment with (+)-nicotine on the stress-induced hypertension and downregulation of central nicotinic receptors in rats: comparative study with (x)-nicotine. General Pharmacology 33, 29-33.
84. Timofeeva OA, Levin ED (2011). Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia. Neuroscience 195, 21-36.
85. Tran TT, Srivareerat M, Alhaider IA, Alkadhi KA (2011a). Chronic psychosocial stress enhances long-term depression in a subthreshold amyloid-beta rat model of Alzheimer's disease. Journal of Neurochemistry 119, 408-416.
86. Tran TT, Srivareerat M, Alkadhi KA (2010). Chronic psychosocial stress triggers cognitive impairment in a novel at-risk model of Alzheimer's disease. Neurobiology of Disease 37, 756-763.
87. Tran TT, Srivareerat M, Alkadhi KA (2011b). Chronic psychosocial stress accelerates impairment of long-term memory and late-phase long-term potentiation in an at-risk model of Alzheimer's disease. Hippocampus 21, 724-732.
88. Wesnes K, Warburton DM (1984). Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berlin) 82, 147-150.
89. White HK, Levin ED (1999). Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology (Berlin) 143, 158-165.
90. Yu W, Mechawar N, Krantic S, Quirion R (2011). alpha7 Nicotinic receptor activation reduces beta-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. Journal of Neurochemistry 119, 848-858.
91. Yun J, Koike H, Ibi D, Toth E, et al. (2010). Chronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brain-specific transcription factor Npas4. Journal of Neurochemistry 114, 1840-1851.